Show
Sort by
-
Cannabis allergy : a diagnostic challenge
-
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
-
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
-
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
-
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition
-
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
-
Healthcare consumption and direct costs of rheumatoid arthritis in Belgium
-
Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients